FRONTIER5: Safety and patient experience of a direct switch from emicizumab to denecimig (Mim8) in patients with haemophilia A with or without inhibitors.
Journal of thrombosis and haemostasis : JTH
View this publicationMember
Medical Faculty, University of Bonn University Hospital of Bonn Sigmund-Freud-Strasse 25 53127 Bonn
Journal of thrombosis and haemostasis : JTH
View this publicationHamostaseologie
View this publicationNature communications
View this publication